Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Broad bean flour (Vicia faba) is a nutrient-dense legume flour rich in bioactive peptides that inhibit angiotensin-converting enzyme (ACE) by up to 60% and dipeptidyl peptidase IV (DPP-IV) by 11% following simulated gastrointestinal digestion, conferring antihypertensive and antidiabetic properties. Its protein isolates demonstrate superior functional characteristics—including high water absorption, emulsifying capacity, and foaming stability—while germination further enhances protein digestibility and reduces antinutritional factors such as tannins and phytic acid (PMID: 3231250).
Reported Benefits (Provisional)
Origin & History
Broad Bean Flour is derived from the dried seeds of Vicia faba, commonly known as broad beans or fava beans. This ancient legume is cultivated globally, with significant historical roots in the Mediterranean, Asia, and North Africa. The flour is a nutrient-dense ingredient, prized for its high plant-based protein, dietary fiber, and essential micronutrients, supporting metabolic and digestive health.
Research Narrative (Provisional)
Rahma et al. (1988) demonstrated that germination of faba bean flour significantly improved protein solubility, emulsifying activity, and foaming properties while altering electrophoretic protein profiles, suggesting enhanced digestibility and functionality (PMID: 3231250). Gangola et al. (2022) found that crackers supplemented with faba bean whole flour, starch concentrate, and protein isolate exhibited modified in vitro starch digestibility and improved nutritional composition, including higher protein and fiber content (PMID: 35267277). The same research group showed that fortifying durum wheat pasta with faba bean meal, starch, or protein differentially influenced noodle composition and lowered predicted glycemic index through altered starch structure (PMID: 33567351). Ceramella et al. (2022) reported that Vicia faba pod extracts exhibited significant anticancer activity against breast and colon cancer cell lines alongside strong antioxidant capacity, attributable to phenolic compounds including flavonoids and hydroxycinnamic acids (PMID: 35996664).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Protein: Vital for muscle repair and growth. - Dietary Fiber: Supports digestive health, promotes satiety, and balances blood sugar. - Folate: Essential for cell division, DNA synthesis, and red blood cell formation. - Iron: Vital for oxygen transport in the body and energy metabolism. - Potassium & Magnesium: Promote heart health, muscle function, and electrolyte balance. - Polyphenols: Potent antioxidants that protect against oxidative damage and inflammation.
Reported Mechanism (Provisional)
Bioactive peptides released during gastrointestinal digestion of broad bean flour proteins competitively bind the active site of angiotensin-converting enzyme (ACE), blocking the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and thereby reducing peripheral vascular resistance and blood pressure. These peptides simultaneously inhibit dipeptidyl peptidase IV (DPP-IV), preventing the enzymatic degradation of incretin hormones GLP-1 and GIP, which prolongs insulin secretion and improves postprandial glucose regulation. Phenolic compounds—particularly kaempferol, quercetin glycosides, and hydroxycinnamic acid derivatives—present in Vicia faba scavenge reactive oxygen species (ROS) via electron donation to free radicals, activate the Nrf2/ARE antioxidant response pathway, and exhibit pro-apoptotic activity against cancer cells through caspase-dependent mechanisms (PMID: 35996664). The high soluble fiber fraction (including galactooligosaccharides and resistant starch) resists upper-gut digestion, undergoes colonic fermentation to produce short-chain fatty acids (SCFAs) such as butyrate and propionate, which downregulate hepatic cholesterol synthesis via inhibition of HMG-CoA reductase and support gut epithelial integrity.
Clinical Narrative (Provisional)
Current evidence is primarily based on in vitro and animal studies rather than human clinical trials. In vitro digestion studies show ACE inhibition increased from 23% to 60% and DPP-IV inhibition from 3% to 11% following simulated gastrointestinal digestion. Animal studies in mice demonstrated reduced atherogenic markers when fed faba bean hydrolysates. The lack of human clinical trials represents a significant limitation in the current evidence base for broad bean flour's therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.